Insider Selling: Globe Life (NYSE:GL) CEO Sells $1,809,750.00 in Stock

Globe Life Inc. (NYSE:GL) CEO Frank Svoboda sold 12,500 shares of the company’s stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total transaction of $1,809,750.00. Following the sale, the chief executive officer directly owned 35,868 shares of the company’s stock, valued at approximately $5,192,969.04. This represents a 25.84% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Globe Life Stock Performance

NYSE:GL opened at $144.41 on Friday. Globe Life Inc. has a 52-week low of $109.38 and a 52-week high of $152.71. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.07 and a current ratio of 0.07. The company has a market cap of $11.50 billion, a price-to-earnings ratio of 10.26 and a beta of 0.47. The firm’s 50-day moving average is $141.43 and its 200-day moving average is $138.59.

Globe Life (NYSE:GL) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The business had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same quarter in the prior year, the company posted $3.14 EPS. The company’s quarterly revenue was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Equities research analysts anticipate that Globe Life Inc. will post 13.87 earnings per share for the current year.

Hedge Funds Weigh In On Globe Life

A number of hedge funds have recently added to or reduced their stakes in the stock. Compound Planning Inc. grew its stake in shares of Globe Life by 4.3% in the 4th quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock worth $275,000 after acquiring an additional 82 shares in the last quarter. Transcend Capital Advisors LLC grew its holdings in shares of Globe Life by 3.9% during the fourth quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock worth $317,000 after purchasing an additional 84 shares in the last quarter. Natural Investments LLC increased its stake in Globe Life by 2.6% in the fourth quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock valued at $482,000 after acquiring an additional 87 shares during the last quarter. Parallel Advisors LLC raised its stake in shares of Globe Life by 5.6% during the fourth quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock worth $231,000 after acquiring an additional 87 shares in the last quarter. Finally, Intech Investment Management LLC lifted its stake in shares of Globe Life by 0.8% in the 2nd quarter. Intech Investment Management LLC now owns 11,572 shares of the company’s stock valued at $1,438,000 after acquiring an additional 95 shares during the last quarter. Institutional investors and hedge funds own 81.61% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently commented on the company. Keefe, Bruyette & Woods raised their price objective on Globe Life from $160.00 to $162.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 28th. Wells Fargo & Company cut their price objective on Globe Life from $172.00 to $170.00 and set an “overweight” rating for the company in a research report on Friday, October 24th. Evercore set a $157.00 price target on Globe Life in a research note on Wednesday. Weiss Ratings upgraded Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, February 13th. Finally, Morgan Stanley reissued an “overweight” rating and issued a $176.00 target price on shares of Globe Life in a report on Monday, December 15th. Eight analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $171.22.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.